Fezolinetant Changes Menopause Management, with JoAnn Vensko Pinkerton, MD
Pinkerton reflects on the breakthrough approval for the non-estrogen, non-hormonal daily oral drug earlier this year.
Celeste Krewson Joann Vensko Pinkerton Astellas Pharma Drug Administration Menopause Society University Of Virginia
Source: hcplive.com